Enzo Biochem, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 79   

Articles published

ENZ 3.01 -0.02 (-0.66%)
price chart
Enzo Biochem Inc. (ENZ) is Trading Lower on Unusual Volume for April 24
Enzo Biochem Inc. (ENZ) experienced unusually high volume on Apr. 24, as the stock lost 0.66% to a closing price of $3.01. The stock saw 488,875 shares trade hands over the course of the day on 1,042 trades.
Enzo Biochem, Inc. v. Applera Corp. (Fed. Cir. 2010)
Enzo The '824, '767, '928, and '830 patents, which are owned by Plaintiffs-Appellants Enzo Biochem, Inc., Enzo Life Sciences, Inc., and Yale University ("Enzo"), are directed to various techniques for labeling and detecting nucleic acids. More ...
Enzo Biochem Inc. v. Applera Corp. (Fed. Cir. 2015)
This is what the Federal Circuit held earlier this week in the Enzo Biochem Inc. v. Applera Corp. case. Writing for the majority, Chief Judge Prost noted that the intrinsic evidence for a patent related to modifying polynucleotides to be used with ...
Enzo Biochem Inc. Files SEC Form SC 13G, Statement of Acquisition of ...
By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C. , by NewsRx journalists, a U.S.
Enzo Biochem Announces Appointment of James M. O'Brien as Senior VP ...
Jim has held leadership positions in the areas of planning and strategic development, financial analysis, SEC reporting and internal controls for both large and small multi-national public companies,� said Barry Weiner, President of Enzo Biochem, Inc ...
Enzo Biochem Unit Partners with Innate Pharma SA to Validate Key System for ...  MarketWatch
Healthcare Stocks Little Changed; Enzo Biochem, Innate Pharma Partnering on ...  NASDAQ
Related articles »  
Could Enzo Biochem's Intellectual Property Lawsuits Be Worth Billions?
Enzo Biochem, Inc. (NYSE:ENZ) is an integrated life sciences and biotechnology company divided into three segments: Enzo Clinical Labs, Enzo Life Sciences, and Enzo Therapeutics.
BRIEF-Patent verdict favoring Enzo Biochem is reversed by US appeals court
March 16 (Reuters) - Enzo Biochem Inc : * U.S. appeals court rules in favor of applera corp and against Enzo Biochem. Inc in patent infringement case -- court ruling * U.S.
Enzo Biochem stock plunges after $61M Applera judgment tossed
(Bloomberg) -- Enzo Biochem Inc. fell after an appeals court threw out a $61 million judgment it won against Thermo Fisher Scientific Inc.'s Applera unit over genetic research and screening.
Federal Circuit tosses jury award for Enzo Biochem
NEW YORK (Reuters) - A federal appeals court Monday threw out a nearly $49 million jury award for Enzo Biochem Inc, saying a lower court judge's interpretation of the company's patent was incorrect.
Enzo Biochem to Request Rehearing of Court of Appeals Decision  MarketWatch
Bad grammar: Fed. Circuit's claim construction splits an infinitive in Enzo ...
And she would have agreed with Judge Newman (and me) that the majority erred in its March 16, 2015 ruling in Enzo Biochem Inc. v. Applera Corp.http://tinyurl.com/q6gfpbj. At issue was whether U.S. Pat. No. 5,449,767, originally assigned to Yale ...